从支付方角度看急性冠脉综合征的经济负担:贝弗里奇模式下的卫生系统。

IF 3.7 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Layla Abdullah Mahdi , Ali Azeez Al-Jumaili , Cole G. Chapman
{"title":"从支付方角度看急性冠脉综合征的经济负担:贝弗里奇模式下的卫生系统。","authors":"Layla Abdullah Mahdi ,&nbsp;Ali Azeez Al-Jumaili ,&nbsp;Cole G. Chapman","doi":"10.1016/j.sapharm.2025.02.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Cost of illness (COI) studies provide crucial data to policymakers for prioritizing resource allocation, particularly in Iraq that lacks such studies. The objective of this COI study was to measure the direct medical costs for acute coronary syndrome (ACS) during hospitalization from the payer perspective.</div></div><div><h3>Methods</h3><div>This multi-source hospital-based study collected data from patient medical records, healthcare providers, and hospital administration from December 2023 through January 2024. This study was conducted in a leading public cardiac hospital in Iraq, which serves a diverse patient population from across the country. The direct medical costs of ACS treatment were calculated from the payer's point of view (the Ministry of Health (MOH)) for patients admitted to the public department and from the patient's point of view for those admitted to the private department.</div></div><div><h3>Results</h3><div>The study included 70 patients; 50 in the public department and 20 in the private department. The average cost of ACS treatment during hospitalization for a single patient in the public department was Iraqi Dinar (IQD) 1,101,390 ($725). The coronary angiography/angioplasty (CAA) procedure was the largest contributor to spending, accounting for 72.12 % of total expenditures. The patients who were admitted to the private department paid IQD 864,375 ($569) per patient, on average.</div></div><div><h3>Conclusion</h3><div>This study developed a pragmatic approach to calculate cost-of-illness for health systems following the Beveridge Health Model and do not have specific fees for each service. The Iraqi MOH covers all the expenses in the public department within the public hospitals. Although the patients pay fees for ACS treatment in the private department, the MOH may provide subsidized prices to reduce the actual costs.This study opens the door to study the cost of illness for other diseases in the future and informs the payers about the required budget allocation. The study methods are potentially transferable to any country utilizing the Beveridge Model for healthcare delivery.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"21 5","pages":"Pages 417-423"},"PeriodicalIF":3.7000,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Economic burden of acute coronary syndrome from payer perspective in a health system following the Beveridge Model\",\"authors\":\"Layla Abdullah Mahdi ,&nbsp;Ali Azeez Al-Jumaili ,&nbsp;Cole G. Chapman\",\"doi\":\"10.1016/j.sapharm.2025.02.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Cost of illness (COI) studies provide crucial data to policymakers for prioritizing resource allocation, particularly in Iraq that lacks such studies. The objective of this COI study was to measure the direct medical costs for acute coronary syndrome (ACS) during hospitalization from the payer perspective.</div></div><div><h3>Methods</h3><div>This multi-source hospital-based study collected data from patient medical records, healthcare providers, and hospital administration from December 2023 through January 2024. This study was conducted in a leading public cardiac hospital in Iraq, which serves a diverse patient population from across the country. The direct medical costs of ACS treatment were calculated from the payer's point of view (the Ministry of Health (MOH)) for patients admitted to the public department and from the patient's point of view for those admitted to the private department.</div></div><div><h3>Results</h3><div>The study included 70 patients; 50 in the public department and 20 in the private department. The average cost of ACS treatment during hospitalization for a single patient in the public department was Iraqi Dinar (IQD) 1,101,390 ($725). The coronary angiography/angioplasty (CAA) procedure was the largest contributor to spending, accounting for 72.12 % of total expenditures. The patients who were admitted to the private department paid IQD 864,375 ($569) per patient, on average.</div></div><div><h3>Conclusion</h3><div>This study developed a pragmatic approach to calculate cost-of-illness for health systems following the Beveridge Health Model and do not have specific fees for each service. The Iraqi MOH covers all the expenses in the public department within the public hospitals. Although the patients pay fees for ACS treatment in the private department, the MOH may provide subsidized prices to reduce the actual costs.This study opens the door to study the cost of illness for other diseases in the future and informs the payers about the required budget allocation. The study methods are potentially transferable to any country utilizing the Beveridge Model for healthcare delivery.</div></div>\",\"PeriodicalId\":48126,\"journal\":{\"name\":\"Research in Social & Administrative Pharmacy\",\"volume\":\"21 5\",\"pages\":\"Pages 417-423\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-02-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Research in Social & Administrative Pharmacy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1551741125000312\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Social & Administrative Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551741125000312","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

背景:疾病成本(COI)研究为政策制定者优先分配资源提供了重要数据,特别是在缺乏此类研究的伊拉克。本COI研究的目的是从付款人的角度衡量急性冠脉综合征(ACS)住院期间的直接医疗费用。方法:这项基于医院的多源研究收集了2023年12月至2024年1月期间患者医疗记录、医疗保健提供者和医院管理部门的数据。这项研究是在伊拉克一家主要的公立心脏病医院进行的,该医院为来自全国各地的各种患者提供服务。对于公立部门的患者,从付款人(卫生部)的角度计算ACS治疗的直接医疗费用;对于私立部门的患者,从患者的角度计算ACS治疗的直接医疗费用。结果:纳入70例患者;公共部门50人,私人部门20人。在公共部门,单个患者住院期间ACS治疗的平均费用为伊拉克第纳尔(IQD) 1,101,390(725美元)。冠状动脉造影/血管成形术(CAA)是支出的最大贡献者,占总支出的72.12%。在私立医院就诊的患者平均每人支付864,375英镑(569美元)。结论:本研究开发了一种实用的方法来计算卫生系统的疾病成本,遵循贝弗里奇健康模型,而不是为每项服务设定特定的费用。伊拉克卫生部承担公立医院公共部门的所有费用。虽然患者在私营部门支付ACS治疗费用,但卫生部可能会提供补贴价格,以降低实际成本。这项研究为未来研究其他疾病的疾病成本打开了大门,并告知支付者所需的预算分配。研究方法有可能转移到任何国家利用贝弗里奇模式的医疗保健服务。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Economic burden of acute coronary syndrome from payer perspective in a health system following the Beveridge Model

Background

Cost of illness (COI) studies provide crucial data to policymakers for prioritizing resource allocation, particularly in Iraq that lacks such studies. The objective of this COI study was to measure the direct medical costs for acute coronary syndrome (ACS) during hospitalization from the payer perspective.

Methods

This multi-source hospital-based study collected data from patient medical records, healthcare providers, and hospital administration from December 2023 through January 2024. This study was conducted in a leading public cardiac hospital in Iraq, which serves a diverse patient population from across the country. The direct medical costs of ACS treatment were calculated from the payer's point of view (the Ministry of Health (MOH)) for patients admitted to the public department and from the patient's point of view for those admitted to the private department.

Results

The study included 70 patients; 50 in the public department and 20 in the private department. The average cost of ACS treatment during hospitalization for a single patient in the public department was Iraqi Dinar (IQD) 1,101,390 ($725). The coronary angiography/angioplasty (CAA) procedure was the largest contributor to spending, accounting for 72.12 % of total expenditures. The patients who were admitted to the private department paid IQD 864,375 ($569) per patient, on average.

Conclusion

This study developed a pragmatic approach to calculate cost-of-illness for health systems following the Beveridge Health Model and do not have specific fees for each service. The Iraqi MOH covers all the expenses in the public department within the public hospitals. Although the patients pay fees for ACS treatment in the private department, the MOH may provide subsidized prices to reduce the actual costs.This study opens the door to study the cost of illness for other diseases in the future and informs the payers about the required budget allocation. The study methods are potentially transferable to any country utilizing the Beveridge Model for healthcare delivery.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Research in Social & Administrative Pharmacy
Research in Social & Administrative Pharmacy PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
7.20
自引率
10.30%
发文量
225
审稿时长
47 days
期刊介绍: Research in Social and Administrative Pharmacy (RSAP) is a quarterly publication featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信